Search
Descriptor English: Antiparkinson Agents
Descriptor Spanish: Antiparkinsonianos
Descriptor antiparkinsonianos
Entry term(s) fármacos antiparkinsonianos
Scope note: Fármacos que se usan para tratar la enfermedad de Parkinson. Los fármacos más utilizados actúan en el sistema dopaminérgico, en el cuerpo estriado y en los ganglios basales, o bien son antagonistas muscarínicos de acción central.
Descriptor Portuguese: Antiparkinsonianos
Descriptor French: Antiparkinsoniens
Entry term(s): Agents, Antiparkinson
Agents, Antiparkinsonian
Antiparkinson Drugs
Antiparkinsonian Agents
Antiparkinsonians
Drugs, Antiparkinson
Tree number(s): D27.505.954.427.090.050
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000978
Scope note: Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists.
Annotation: general or unspecified; prefer specifics
Allowable Qualifiers: AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Previous Indexing: Parasympatholytics (1966-1972)
Parkinsonism/drug therapy (1966-1972)
Public MeSH Note: 76; was ANTIPARKINSON DRUGS 1973-75; was ANTIPARKINSON DRUGS see under PARASYMPATHOLYTICS 1963-72
Online Note: use ANTIPARKINSON AGENTS to search ANTIPARKINSON DRUGS 1972-75 (as Prov 1972) & PARASYMPATHOLYTICS 1966-71
History Note: 76; was ANTIPARKINSON DRUGS 1972-75 (Prov 1972); was ANTIPARKINSON DRUGS see under PARASYMPATHOLYTICS 1963-72
DeCS ID: 982
Unique ID: D000978
NLM Classification: QV 80
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1973/01/01
Date of Entry: 1999/01/01
Revision Date: 2005/06/30
Antiparkinson Agents - Preferred
Concept UI M0001494
Scope note Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists.
Preferred term Antiparkinson Agents
Entry term(s) Agents, Antiparkinson
Agents, Antiparkinsonian
Antiparkinson Drugs
Antiparkinsonian Agents
Antiparkinsonians
Drugs, Antiparkinson



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey